Literature DB >> 30575917

MiR-4282 inhibits proliferation, invasion and metastasis of human breast cancer by targeting Myc.

J Zhao1, G-Q Jiang.   

Abstract

OBJECTIVE: To investigate the expression and role of MicroRNA 4282 (miR-4282) in the development of breast cancer.
MATERIALS AND METHODS: In situ hybridization was performed to investigate the expression of miR-4282 in human breast cancer tissues. Cell lines stably over-expressed miR-4282 were established by lentivirus transfection. The effects of miR-4282 on the biological behavior of breast cancer cells were then explored in vitro.
RESULTS: The results showed that miR-4282 was down-regulated in human breast cancer tissues and was particularly in invasive and metastatic tumors. In addition, the expression of miR-4282 was related to the occurrence of metastasis and the clinical grade of breast cancer. Recovery of miR-4282 expression in the cell could inhibit the proliferation of breast cancer cells, blocked G1-S phase and promoted breast cancer cell apoptosis, inhibited breast cancer cell migration and invasion. Besides, miR-4282 also significantly enhanced the sensitivity of breast cancer cells to paclitaxel. The results of bioinformatics analysis combined with qRT-PCR and Western blot demonstrated that Myc might be the target gene of miR-4282 in breast cancer.
CONCLUSIONS: miR-4282 inhibited the occurrence and development of breast cancer by regulating Myc, which made it a new target for clinical diagnosis and treatment of breast cancer.

Entities:  

Year:  2018        PMID: 30575917     DOI: 10.26355/eurrev_201812_16643

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  MicroRNA-215-3p Suppresses the Growth, Migration, and Invasion of Colorectal Cancer by Targeting FOXM1.

Authors:  Xiaowei Tang; Xianfeng Shi; Nianfei Wang; Wanren Peng; Zhendong Cheng
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec

Review 2.  MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer.

Authors:  Mohammad Mijanur Rahman; Andrew C Brane; Trygve O Tollefsbol
Journal:  Cells       Date:  2019-10-08       Impact factor: 6.600

3.  circ_103809 promotes breast cancer progression by regulating the PI3K/AKT signaling pathway.

Authors:  Xiaoli Qiu; Qinghua Wang; Huiping Song; Di Shao; Jie Xue
Journal:  Oncol Lett       Date:  2020-04-02       Impact factor: 2.967

4.  Network potential identifies therapeutic miRNA cocktails in Ewing sarcoma.

Authors:  Davis T Weaver; Kathleen I Pishas; Drew Williamson; Jessica Scarborough; Stephen L Lessnick; Andrew Dhawan; Jacob G Scott
Journal:  PLoS Comput Biol       Date:  2021-10-18       Impact factor: 4.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.